pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Preclinical
    MB-204
    Alzheimer's Disease Marvel Biotechnology Inc
  • Preclinical
    MBP-091
    Marburgvirus Infections (Marburg Hemorrhagic Fever) Mapp Biopharmaceutical Inc
  • Phase 1
    MBP-134
    Ebolavirus Infections (Ebola Hemorrhagic Fever) Mapp Biopharmaceutical Inc
  • Phase 1
← prev
page 122 of 271
next →
Pain89
Neurology1
MBQ-167
Triple-Negative Breast Cancer (TNBC)
MBQ Pharma Inc
  • Phase 1
    MBX-4291
    Obesity$MBX MBX Biosciences, Inc.
  • Phase 2
    MC-001
    Spinal Cord Injury StemCyte Inc
  • Phase 3
    MC-1
    heart failure$MCUJF MEDICURE INC
  • Preclinical
    MC-16
    Retinitis Pigmentosa (Retinitis) Mitochem Therapeutics, LLC
  • Phase 2
    MC-232
    Hidradenitis Suppurativa MC2 Therapeutics AS
  • Phase 1
    MCLA-145
    Solid Tumor Merus NV
  • Phase 1
    MCM-998
    Multiple Myeloma (Kahler Disease)$NVS NOVARTIS AG
  • Preclinical
    MCR-231
    Neurotrophic Keratitis MicroCures Inc
  • Preclinical
    MDC-STM
    ivermectin
    Malaria MedinCell SA
  • Preclinical
    MDC-WWM
    Female Contraception MedinCell SA
  • Phase 2
    MDI-1228
    Diabetic Foot Ulcers Henan Maiyingnuo Pharmaceutical Technology Co Ltd
  • Preclinical
    MDL-101
    Laminin-Deficient Congenital Muscular Dystrophy (LAMA2 MD… Modalis Therapeutics Corp
  • Preclinical
    MDL-204
    Unspecified Central Nervous System Disorders Modalis Therapeutics Corp
  • Preclinical
    MDMA Patch
    Unspecified Psychiatric Disorders PharmaTher Holdings Ltd
  • Phase 2
    MDNA-11
    Solid Tumor$MDNAF Medicenna Therapeutics Corp.
  • Phase 2
    MDX-1097
    Refractory Multiple Myeloma HaemaLogix Pty Ltd
  • Phase 1
    MDX-2301
    Coronavirus Disease 2019 (COVID-19) ModeX Therapeutics Inc
  • Preclinical
    ME-101
    Neonatal Respiratory Distress Syndrome Molecular Express Inc
  • Phase 1
    MEB-1170
    Pain Mebias Discovery LLC
  • Phase 2
    MEDI-0457
    Oropharyngeal Cancer$AZN ASTRAZENECA PLC
  • MEGATOPE
    MEGATOPE (IODINATED I-131 ALBUMIN)
    no indication ISO TEX
  • Phase 1
    MEI-004
    Alopecia Nanjing Mainowei Pharmaceutical Technology Co Ltd.
  • MEKINIST
    MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE)
    1 INDICATIONS AND USAGE MEKINIST is a kinase inhibitor in…$NVS NOVARTIS AG
  • Phase 1
    MEM-288
    Cutaneous Squamous Cell Carcinoma (cSCC) Memgen Inc
  • MEMANTINE
    MEMANTINE
    no indication DR REDDYS LABS LTD
  • Preclinical
    MEMPD-119
    Parkinson's Disease GB Sciences Inc